Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $14
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 to $14.
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 to $14.